SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DEGLI UBERTI, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.320
EU - Europa 8.261
AS - Asia 6.492
SA - Sud America 582
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 7
Totale 39.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.249
CN - Cina 2.755
DE - Germania 2.683
SG - Singapore 2.366
UA - Ucraina 1.980
TR - Turchia 1.130
IT - Italia 1.021
GB - Regno Unito 696
FI - Finlandia 575
BR - Brasile 538
SE - Svezia 472
RU - Federazione Russa 356
PL - Polonia 155
FR - Francia 98
BE - Belgio 70
CA - Canada 56
HK - Hong Kong 46
NL - Olanda 42
ZA - Sudafrica 28
ID - Indonesia 24
IR - Iran 24
IN - India 21
AT - Austria 19
IQ - Iraq 18
MA - Marocco 18
LT - Lituania 17
BD - Bangladesh 15
EU - Europa 14
PK - Pakistan 14
IE - Irlanda 13
UZ - Uzbekistan 12
AR - Argentina 11
CZ - Repubblica Ceca 11
RO - Romania 10
VN - Vietnam 10
EC - Ecuador 9
JP - Giappone 9
VE - Venezuela 8
MX - Messico 7
CH - Svizzera 6
DK - Danimarca 6
KG - Kirghizistan 6
AU - Australia 5
KE - Kenya 5
MY - Malesia 5
NP - Nepal 5
PT - Portogallo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EG - Egitto 4
ES - Italia 4
HU - Ungheria 4
JO - Giordania 4
PE - Perù 4
PY - Paraguay 4
BO - Bolivia 3
CL - Cile 3
CY - Cipro 3
DZ - Algeria 3
KZ - Kazakistan 3
LB - Libano 3
MD - Moldavia 3
PH - Filippine 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CO - Colombia 1
GA - Gabon 1
IL - Israele 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
NO - Norvegia 1
OM - Oman 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
UY - Uruguay 1
Totale 39.744
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.027
Fairfield 2.448
Jacksonville 2.158
Chandler 2.078
Ashburn 1.738
Houston 1.721
Santa Clara 1.317
Ann Arbor 1.271
Singapore 1.093
Wilmington 950
Seattle 939
Cambridge 747
Izmir 676
Nanjing 616
Beijing 546
Princeton 439
Addison 384
San Diego 275
Boardman 267
Milan 215
Shenyang 198
Shanghai 192
Nanchang 180
Helsinki 176
New York 165
Dearborn 163
Warsaw 154
Los Angeles 138
Ferrara 135
Hebei 134
Changsha 112
Bremen 109
Tianjin 107
Washington 107
Jiaxing 97
Jinan 83
Falls Church 69
Mountain View 67
Brussels 64
San Mateo 62
London 56
Kunming 47
Norwalk 47
Zhengzhou 46
Ningbo 45
Hong Kong 44
Redwood City 44
Guangzhou 43
Carrara 40
Munich 39
Falkenstein 38
Auburn Hills 36
Tappahannock 36
Taizhou 34
Leawood 30
Frankfurt am Main 29
Toronto 29
Düsseldorf 28
Orange 28
São Paulo 28
Des Moines 26
Indiana 25
Hefei 24
Belo Horizonte 23
Augusta 22
Hangzhou 21
Jakarta 20
Nuremberg 20
Rio de Janeiro 20
Rome 20
Verona 20
Bologna 18
Monmouth Junction 18
Ardabil 17
Philadelphia 17
The Dalles 17
Lanzhou 15
Ottawa 14
Changchun 13
Curitiba 13
Ferrara di Monte Baldo 12
Haikou 11
Porto Alegre 11
Padova 10
Redmond 10
Chengdu 9
Dong Ket 9
San Francisco 9
Baghdad 8
Brasília 8
Chicago 8
Kilburn 8
Mumbai 8
Tashkent 8
Walnut 8
Yellow Springs 8
Campinas 7
Dublin 7
Fuzhou 7
Hounslow 7
Totale 26.740
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 344
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 251
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 181
Igf-I influences everolimus activity in medullary thyroid carcinoma 177
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 171
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 170
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 167
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 167
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 165
Circadian profile of plasma calcitonin gene-related peptide in healthy man 164
ROLL technique application for Minimally-Invasive Radioguided Parathyroidectomy (MIRP) in Hyperparathyroidism (HPT) 164
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 160
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 160
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 158
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 158
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 158
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 155
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 154
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 153
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 151
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 149
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 147
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 147
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 144
Functional characterization of a new deletion in CDKN1B 5'-UTR region 142
Characterization of a deleted Y chromosome in a male with Turner stigmata 142
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide 140
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine needle aspiration biopsies. 140
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 139
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 138
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 138
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 138
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 136
Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach 136
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 135
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 134
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 134
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 134
Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide 133
Dermorphin inhibits spinal nociceptive flexion reflex in humans 132
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 132
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 131
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 131
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 130
null 130
Atrial strain is the main determinant of release of atrial natriuretic peptide 129
Role of the serotonergic system in the genesis of vasovagal syncope. 129
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 129
Pituitary side effects of old and new drugs. 129
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 129
Post-partum thyroiditis - A clinical update 128
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 128
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 128
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 127
Cerebral aneurysm and acromegaly: a case report 127
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 127
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 127
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 127
In vitro testing of new somatostatin analogs on pituitary tumor cells 126
Rare diseases in clinical endocrinology: a taxonomic classification system. 126
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 126
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 126
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 126
Iodine excess and hyperthyroidism 125
Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids 125
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 125
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 125
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 124
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 124
Growth hormone excess promotes breast cancer chemoresistance 124
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 124
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 124
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 123
A C-MYC GENE VARIANT WITHOUT EXON 1 AND WITH AN ABNORMAL METHYLATION PATTERN INHERITED IN A WOMAN WITH NO EVIDENCE OF MAMLIGNANCY 122
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 122
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 122
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 122
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 122
Changes of plasma calcitonin gene-related peptide levels in postmenopausal women 122
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 121
Growth hormone and skeletal muscle function 121
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 121
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 120
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 120
L’iperplasia surrenale congenita e la pubertà precoce 120
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 120
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 120
A practical method for the estimation of therapeutic activity in the treatment of Graves' hyperthyroidism 120
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 119
Evidence for androgen receptor gene expression in human thyroid cells and tumours 119
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 119
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 119
null 118
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 118
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 118
Does placebo lower blood pressure in hypertensive patients? A noninvasive chronobiological study 117
Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia 117
Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure 117
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 117
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 117
Totale 13.727
Salva come PNG Salva come JPEG
Categoria #
all - tutte 191.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.454
Totale 203.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.319 0 0 0 0 0 0 0 0 0 827 395 97
2020/20214.416 463 380 205 586 164 495 115 520 68 522 688 210
2021/20224.080 129 416 246 180 192 186 164 183 164 338 437 1.445
2022/20234.399 443 303 175 595 687 658 179 383 578 32 214 152
2023/20242.338 200 274 132 62 204 382 71 462 40 28 34 449
2024/20255.786 230 180 625 210 1.067 876 307 351 1.297 643 0 0
Totale 40.055